Published

Psilocybin and Mescaline - Molecule of the Month October 1999 [Archived version]

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Bristol Research (University of Bristol)
Date: 2017-07-25
Source: OpenAlex
DOI: 10.6084/m9.figshare.5245549
PubMed: Unavailable

Authors

Paul May

Watch author

Derived topics and classifications

psilocybin General Other

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Examining Attitudes to Psilocybin: Should Candidates for Medical Psilocybin be Required to Pass a Contextual Suitability Test?Journal of Humanistic Psychology · 2022-08-18 Skinner, Maslow, and PsilocybinJournal of Humanistic Psychology · 1993-07-01 Pattern of psychedelic substance use: a comparison between populations in Spain and South America using the Psychedelic Use Scale (PUS)Current Psychology · 2024-11-21 Expectancies for Subjective and Antidepressant Effects in Psilocybin UsersJournal of Humanistic Psychology · 2023-09-22 A-118 Psychedelic Interventions for Neuropsychological ConditionsArchives of Clinical Neuropsychology · 2022-08-16 A Qualitative Exploration of Relational Ethical Challenges and Practices in Psychedelic HealingJournal of Humanistic Psychology · 2021-09-16 Psychedelics as a Training Experience for Psychedelic Therapists: Drawing on History to Inform Current PracticeJournal of Humanistic Psychology · 2021-06-23 Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological AnalysisJournal of Humanistic Psychology · 2017-04-28